Skip to main content
. 2008 Feb 12;19(4):399–428. doi: 10.1007/s00198-008-0560-z

Table 19.

Cost-effectiveness of alendronate (cost £000/QALY gained) in women with clinical risk factors and no information on BMDa

Age (years) Prior fracture Secondary OP FH Smoking c.s. Alcohol
50 28.6 46.4 32.1 64.6 43.8 52.1
55 27.1 42.2 29.9 60.1 41.0 47.7
60 23.2 35.4 25.9 52.5 36.1 40.2
65 11.5 17.5 13.4 27.7 18.5 20.2
70 6.3 9.5 7.5 16.6 10.0 11.6
75 5.2 7.0 c.s. 14.8 6.3 9.8
80 c.s. c.s. c.s. 4.7 c.s. 2.2

Calculations are based on the UK (see text for details)

aBMI set at 26 kg/m2